A
Adami, A.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Ade-Hall, R. A.
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Alonso, Alvaro
- Temporal trends in the incidence of multiple sclerosisA systematic reviewAlvaro Alonso, Miguel A. Hernán
Ames, M. H.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
Anzola, G. P.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Arzy, Shahar
- PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSISShahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker
B
Ben-Hur, Tamir
- PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSISShahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker
Bhatt, Archit
- Teaching NeuroImage: Spindle cell oncocytoma of the pituitary glandMuhammad U. Farooq, Archit Bhatt, Howard T. Chang
Blatt, J. L.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Bleuse, S.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Byrd, S. C.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
C
Castellotti, B.
- Paroxysmal movement disorders in GLUT1 deficiency syndromeG. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci
Cerini, R.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Chang, Howard T.
- Teaching NeuroImage: Spindle cell oncocytoma of the pituitary glandMuhammad U. Farooq, Archit Bhatt, Howard T. Chang
Clement, F.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Cole, G. M.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Couch, J. R.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
Cummings, J. L.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
D
Defebvre, L.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Destée, A.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Devos, D.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Dwyer, M. G.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
F
Farooq, Muhammad U.
- Teaching NeuroImage: Spindle cell oncocytoma of the pituitary glandMuhammad U. Farooq, Archit Bhatt, Howard T. Chang
Fein, J.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Filippi, M.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Finocchi, C.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Fontoura, P.
Frohman, E. M.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Fryer, J. P.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
G
Gellera, C.
- Paroxysmal movement disorders in GLUT1 deficiency syndromeG. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci
Geschwind, D. H.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Goldstein, J.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
Guerreiro, R. M.
Gylys, K. H.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
H
Hernán, Miguel A.
- Temporal trends in the incidence of multiple sclerosisA systematic reviewAlvaro Alonso, Miguel A. Hernán
Homburger, H.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Howieson, D. B.
- Impact of white matter hyperintensity volume progression on rate of cognitive and motor declineL. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye
Hunter, J.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
K
Kaye, J. A.
- Impact of white matter hyperintensity volume progression on rate of cognitive and motor declineL. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye
Khan, O.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Krecke, K.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Krystkowiak, P.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Kuntz, N. L.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
L
Lanska, Douglas J.
Lassmann, H.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Leker, Ronen R.
- PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSISShahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker
Lener, S. E.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
Lennon, V. A.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Ljøstad, Unn
Lotze, T.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Lucchinetti, C. F.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
M
Mannix, L. K.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
McDonald, S. A.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
McKeon, A.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Medina, L. D.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Mehta, Brijesh P.
- Teaching NeuroImage: Cerebrotendinous xanthomatosisBrijesh P. Mehta, Robert H. Shmerling
Meneghetti, G.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Minagar, A.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Mohamed, K.
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Moore, A. P.
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Moore, M. M.
- Impact of white matter hyperintensity volume progression on rate of cognitive and motor declineL. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye
Moreau, C.
- STN-DBS frequency effects on freezing of gait in advanced Parkinson diseaseC. Moreau, L. Defebvre, A. Destée, S. Bleuse, F. Clement, J. L. Blatt, P. Krystkowiak, D. Devos
Mygland, Åse
N
Nardocci, N.
- Paroxysmal movement disorders in GLUT1 deficiency syndromeG. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci
Nelson, C.
- Impact of white matter hyperintensity volume progression on rate of cognitive and motor declineL. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye
Ness, J. M.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Newman, J. P.
- PRIMARY PROGRESSIVE APHASIA: QUANTITATIVE ANALYSISShahar Arzy, J. P. Newman, Tamir Ben-Hur, Ronen R. Leker
P
Pittock, S. J.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Pozzi-Mucelli, R.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Pratico, D.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Q
Quinn, Joseph
- Detecting Alzheimer disease before it happensThe key to prevention?Joseph Quinn, Marwan N. Sabbagh
R
Racke, M. K.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Reder, A. T.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Rensel, M.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Ringman, J. M.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Rodriguez-Agudelo, Y.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Rosario, E. R.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Rosenbloom, L.
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Rossato, G.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
S
Sabbagh, Marwan N.
- Detecting Alzheimer disease before it happensThe key to prevention?Joseph Quinn, Marwan N. Sabbagh
Schaffer, B.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Seltzer, W.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Sette, M. Del
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Shmerling, Robert H.
- Teaching NeuroImage: Cerebrotendinous xanthomatosisBrijesh P. Mehta, Robert H. Shmerling
Silberstein, S. D.
- Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS. D. Silberstein, L. K. Mannix, J. Goldstein, J. R. Couch, S. C. Byrd, M. H. Ames, S. A. McDonald, S. E. Lener
Silbert, L. C.
- Impact of white matter hyperintensity volume progression on rate of cognitive and motor declineL. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, J. A. Kaye
Smith, C. Tudu
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Sokolow, S.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Stüve, O.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
T
Tagliati, Michele
Tenenbaum, S.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Thijs, V. N.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
V
Varpetian, A.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
W
Walsh, H.P.J.
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Weinshenker, B. G.
- CNS aquaporin-4 autoimmunity in childrenA. McKeon, V. A. Lennon, T. Lotze, S. Tenenbaum, J. M. Ness, M. Rensel, N. L. Kuntz, J. P. Fryer, H. Homburger, J. Hunter, B. G. Weinshenker, K. Krecke, C. F. Lucchinetti, S. J. Pittock
Williamson, P. R.
- Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA. P. Moore, R. A. Ade-Hall, C. Tudu Smith, L. Rosenbloom, H.P.J. Walsh, K. Mohamed, P. R. Williamson
Y
Younkin, S. G.
- Biochemical markers in persons with preclinical familial Alzheimer diseaseJ. M. Ringman, S. G. Younkin, D. Pratico, W. Seltzer, G. M. Cole, D. H. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. R. Rosario, K. H. Gylys, A. Varpetian, L. D. Medina, J. L. Cummings
Z
Zanferrari, C.
- Right-to-left shunt does not increase white matter lesion load in migraine with aura patientsA. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. Del Sette, C. Finocchi, G. Meneghetti, C. Zanferrari
Zibordi, F.
- Paroxysmal movement disorders in GLUT1 deficiency syndromeG. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci
Zivadinov, R.
- Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR. Zivadinov, A. T. Reder, M. Filippi, A. Minagar, O. Stüve, H. Lassmann, M. K. Racke, M. G. Dwyer, E. M. Frohman, O. Khan
Zorzi, G.
- Paroxysmal movement disorders in GLUT1 deficiency syndromeG. Zorzi, B. Castellotti, F. Zibordi, C. Gellera, N. Nardocci
Advertisement
Popular on
Neurology

Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Advertisement